Biggest European listing in a decade set for London

clock • 4 min read
Biggest European listing in a decade set for London

The largest listing on the London Stock Exchange is set to go ahead next week as GlaxoSmithKline investors voted to demerge its newly-created consumer healthcare unit Haleon. The vote to demerge passed overwhelmingly on Wednesday (13 July), with 99.8% voting in favour of the break-up. Next Monday (18 July), the UK's pharmaceutical giant will part ways and Haelon will stand alone as its own stock. It is expected to seek a valuation of around £45bn, making it not only the biggest UK listi...

To continue reading this article...

Join International Investment

Join International Investment today

Unlock members-only benefits:

  • Unlimited access to real-time news, industry insights, video features and market intelligence
  • Stay ahead of the curve with spotlights on international financial centres, regional trends international advice and global industry leaders
  • Receive breaking news stories straight to your inbox in the daily newsletters
  • Hear the latest cross jurisdictional developments in wealth planning, tax, regulation, investing, retirement and protection
  • Members-only access to the Editor’s weekly news roundup newsletter
  • Members-only access to analysis via our exclusive industry polls
  • Be the first to hear about our events and awards programmes

Join now

 

Already a International Investment member?

Login